Literature DB >> 446934

Neural release of glucagon is inhibited by hyperglycemia and enhanced by phentolamine.

R E Miller, E S Horton.   

Abstract

Using an innervated, cross-perfused, canine pancreas-stomach-duodenum preparation, direct neural effects on the immunoreactive glucagon secretion rate (GSR) were separated from blood-borne influences. Both splanchnic nerves were cut above the diaphragm and stimulated simultaneously for three separate 10-min-long periods, twice before and once during a pancreatic arterial phentolamine infusion. The extent of the decreases in GSR that occurred after nerve section was inversely correlated with the arterial plasma glucose concentration at the time of section. Splanchnic nerve stimulation caused a significant increase in GSR. Similar stimulation during a pancreatic arterial phentolamine infusion caused a significantly greater increase. Rapid infusion of glucose near the end of the experiment caused a significant decrease in GSR, demonstrating the responsiveness of the preparation. These data were collected in conjunction with a study of neural influences on insulin secretion rates. It can be concluded that the central nervous system can alter the secretion rate of glucagon by direct neural means. Alpha-adrenergic blockade, in the presence of splanchnic nerve stimulation, enhances GSR.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 446934     DOI: 10.2337/diab.28.8.762

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  3 in total

Review 1.  Neural regulation of the endocrine pancreas.

Authors:  F C Brunicardi; D M Shavelle; D K Andersen
Journal:  Int J Pancreatol       Date:  1995-12

2.  Pancreatic somatostatin secretion is suppressed by splanchnic nerve stimulation.

Authors:  M W Roy; M S Jones; R E Miller
Journal:  Diabetologia       Date:  1981-02       Impact factor: 10.122

3.  Alpha-adrenoceptor involvement in catecholamine-induced hyperglycaemia in conscious fasted rabbits.

Authors:  J Moratinos; B Olmedilla; I de Pablos; M D Vigueras
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.